帕金森病患者采取美多芭联合司来吉兰治疗的效果及安全性观察

张小锋

（陕西渭南蒲城县医院，陕西 渭南，715500）

浏览次数：204次 下载次数：379次

摘要：

目的 探讨美多芭联合司来吉兰治疗帕金森病患者的临床效果和安全性。方法 选择本院收治的帕金森患者98 例，以 简单随机法分为对照组与联合组，各49 例。对照组采取美多芭治疗，联合组采取美多芭联合司来吉兰治疗，对两组患者临床 治疗效果和安全性进行观察比较。结果 治疗后联合组Webster、UPDRS 评分均低于对照组（P<0.05）；联合组治疗总有效率高 于对照组（P<0.05）；两组不良反应情况对比，差异不显著（P>0.05）。结论 美多芭联合司来吉兰治疗可改善帕金森病患者各项 临床症状，提高治疗有效率，且不良反应发生率低，值得临床推广。

关键词：帕金森病；美多芭；司来吉兰

中图分类号：R742.5文献标志码：A文章编号：2096-1413(2018)06-0038-02

Efficacy and safety of madopar combined with selegiline treating on patients with parkinson``s disease
ZHANG Xiao-feng
(the Hospital of Pucheng County, Weinan 715500, China)

ABSTRACT: Objective To investigate the clinical efficacy and safety of madopar combined with selegiline treating on patients with parkinson``s disease. Methods Ninety -eight patients with parkinson``s disease were randomly divided into control group and combination group, with 49 cases in each group. The control group was treated with madopar. The combination group was treated with madopar combined with selegiline. The clinical efficacy and safety of the two groups were compared. Results After treatment the Webster and UPDRS scores of the combination group were lower than those of the control group (P<0.05). The total effective rate of the combined group was higher than that of the control group (P<0.05). There was no significant difference in the adverse reactions between the two groups (P >0.05). Conclusion Madopar combined with selegiline can improve the clinical symptoms of patients with parkinson``s disease, improve the efficiency of treatment, with lower incidence of adverse reactions, which is worthy of clinical promotion.
KEYWORDS: parkinson``s disease; madopar; selegiline

参考文献：
[1] 胡会省,梁艳.美多巴联合盐酸司来吉兰治疗帕金森病的临床疗效观察[J].临床医学,2015,35(1):47-49.
[2] 陈永平,商慧芳.2016 中国帕金森病诊断标准解读[J].中国实用内科杂志,2017,37(2):124-126.
[3] 黄建平,朱文宗.帕金森病诊疗与康复[M].北京:人民军医出版社,2015.
[4] 崔群力.帕金森病非运动症状在评价帕金森病严重程度中的作用[J].中国实用神经疾病杂志,2015,18(8):20-22.
[5] 赵国东,高明明.美多巴联合盐酸司来吉兰治疗帕金森病的临床疗效观察[J].中华临床医师杂志:电子版,2016,10(11):199-200.
[6] 黄少雅,陈旭先,魏敏,等.心理行为干预对帕金森病患者不良情绪及生活质量的影响[J].中国现代医生,2016,54(5):76-78.
[7] 臧广霞.美多巴联合盐酸司来吉兰治疗帕金森病的疗效和安全性分析[J].医学理论与实践,2016,29(4):453-454.
[8] 李波.美多巴联合盐酸司来吉兰治疗帕金森病的疗效和安全性分析[J].中国医学工程,2015,23(11):196.
[9] 杨志刚,林勤郁,潘建青,等.盐酸司来吉兰联合美多巴治疗帕金森病患者的临床效果分析[J].癫癎与神经电生理学杂志,2017,26(2):73-75.
[10] 凌征梅.多巴丝肼片联合盐酸司来吉兰治疗帕金森病患者的疗效和安全性[J].中国药物经济学,2016,11(10):35-37.